BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 25925361)

  • 1. Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.
    Jiang S; Yu H; Wang X; Lu S; Li Y; Feng L; Zhang Y; Heo HY; Lee DH; Zhou J; Wen Z
    Eur Radiol; 2016 Jan; 26(1):64-71. PubMed ID: 25925361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating the histologic grades of gliomas preoperatively using amide proton transfer-weighted (APTW) and intravoxel incoherent motion MRI.
    Zou T; Yu H; Jiang C; Wang X; Jiang S; Rui Q; Mei Y; Zhou J; Wen Z
    NMR Biomed; 2018 Jan; 31(1):. PubMed ID: 29098732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amide Proton Transfer (APT) MR imaging and Magnetization Transfer (MT) MR imaging of pediatric brain development.
    Zhang H; Kang H; Zhao X; Jiang S; Zhang Y; Zhou J; Peng Y
    Eur Radiol; 2016 Oct; 26(10):3368-76. PubMed ID: 26762941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas.
    Durmo F; Rydhög A; Testud F; Lätt J; Schmitt B; Rydelius A; Englund E; Bengzon J; van Zijl P; Knutsson L; Sundgren PC
    PLoS One; 2020; 15(12):e0244003. PubMed ID: 33373375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusional kurtosis imaging for differentiating between high-grade glioma and primary central nervous system lymphoma.
    Pang H; Ren Y; Dang X; Feng X; Yao Z; Wu J; Yao C; Di N; Ghinda DC; Zhang Y
    J Magn Reson Imaging; 2016 Jul; 44(1):30-40. PubMed ID: 26588793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.
    Jiang S; Eberhart CG; Zhang Y; Heo HY; Wen Z; Blair L; Qin H; Lim M; Quinones-Hinojosa A; Weingart JD; Barker PB; Pomper MG; Laterra J; van Zijl PCM; Blakeley JO; Zhou J
    Eur J Cancer; 2017 Sep; 83():9-18. PubMed ID: 28704644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amide proton transfer (APT) and magnetization transfer (MT) in predicting short-term therapeutic outcome in nasopharyngeal carcinoma after chemoradiotherapy: a feasibility study of three-dimensional chemical exchange saturation transfer (CEST) MRI.
    Liu W; Wang X; Xie S; Liu WV; Masokano IB; Bai Y; Chen J; Zhong L; Luo Y; Zhou G; Li W; Pei Y
    Cancer Imaging; 2023 Sep; 23(1):80. PubMed ID: 37658446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion kurtosis imaging differs between primary central nervous system lymphoma and high-grade glioma and is correlated with the diverse nuclear-to-cytoplasmic ratio: a histopathologic, biopsy-based study.
    Haopeng P; Xuefei D; Yan R; Zhenwei Y; Wei H; Ziyin W; Qungang S; Chaojie L; Linyan Y; Zhongmin W; Xiaoyuan F
    Eur Radiol; 2020 Apr; 30(4):2125-2137. PubMed ID: 31858206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of amide proton transfer imaging and magnetization transfer imaging in revealing glioma grades and proliferative activities: a histogram analysis.
    Su C; Jiang J; Liu C; Shi J; Li S; Chen X; Ao Q
    Neuroradiology; 2021 May; 63(5):685-693. PubMed ID: 32997164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging.
    Ding Y; Xing Z; Liu B; Lin X; Cao D
    Brain Behav; 2014; 4(6):841-9. PubMed ID: 25365807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.
    Jiang S; Zou T; Eberhart CG; Villalobos MAV; Heo HY; Zhang Y; Wang Y; Wang X; Yu H; Du Y; van Zijl PCM; Wen Z; Zhou J
    Magn Reson Med; 2017 Sep; 78(3):1100-1109. PubMed ID: 28714279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amide proton transfer-weighted MRI in distinguishing high- and low-grade gliomas: a systematic review and meta-analysis.
    Suh CH; Park JE; Jung SC; Choi CG; Kim SJ; Kim HS
    Neuroradiology; 2019 May; 61(5):525-534. PubMed ID: 30666352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-Dimensional Gradient-Echo-Based Amide Proton Transfer-Weighted Imaging of Brain Tumors: Comparison With Two-Dimensional Spin-Echo-Based Amide Proton Transfer-Weighted Imaging.
    Murayama K; Ohno Y; Yui M; Yamamoto K; Ikedo M; Ohba S; Hanamatsu S; Iwase A; Ikeda H; Hirose Y; Toyama H
    J Comput Assist Tomogr; 2023 May-Jun 01; 47(3):494-499. PubMed ID: 37185016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Differentiation of Low-Grade and High-Grade Gliomas and Detection of Tumor Proliferation Using APT Contrast Fitted from Z-Spectrum.
    Zhang J; Zhu W; Tain R; Zhou XJ; Cai K
    Mol Imaging Biol; 2018 Aug; 20(4):623-631. PubMed ID: 29313159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can amide proton transfer-weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?
    Yu H; Wen X; Wu P; Chen Y; Zou T; Wang X; Jiang S; Zhou J; Wen Z
    Eur Radiol; 2019 Oct; 29(10):5298-5306. PubMed ID: 30887206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical exchange saturation transfer (CEST) MR technique for in-vivo liver imaging at 3.0 tesla.
    Chen SZ; Yuan J; Deng M; Wei J; Zhou J; Wáng YX
    Eur Radiol; 2016 Jun; 26(6):1792-800. PubMed ID: 26334509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying protein-based amide proton transfer MR imaging to distinguish solitary brain metastases from glioblastoma.
    Yu H; Lou H; Zou T; Wang X; Jiang S; Huang Z; Du Y; Jiang C; Ma L; Zhu J; He W; Rui Q; Zhou J; Wen Z
    Eur Radiol; 2017 Nov; 27(11):4516-4524. PubMed ID: 28534162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
    Choi YS; Ahn SS; Lee SK; Chang JH; Kang SG; Kim SH; Zhou J
    Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging.
    Kang XW; Xi YB; Liu TT; Wang N; Zhu YQ; Wang XR; Guo F
    BMC Med Imaging; 2020 May; 20(1):50. PubMed ID: 32408867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.